HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Yoshinobu Kanda Selected Research
Yoshinobu Kanda Research Topics
Disease
71
Graft vs Host Disease (Graft-Versus-Host Disease)
03/2024 - 03/2002
70
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2024 - 10/2008
46
Leukemia
06/2023 - 04/2002
35
Infections
11/2023 - 03/2002
34
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2024 - 10/2008
33
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
04/2024 - 03/2003
32
Neoplasms (Cancer)
05/2024 - 04/2002
25
Multiple Myeloma
05/2024 - 10/2009
23
Aplastic Anemia (Anemia, Hypoplastic)
05/2024 - 01/2007
23
Hematologic Neoplasms (Hematological Malignancy)
12/2023 - 04/2002
20
Lymphoma (Lymphomas)
12/2022 - 04/2002
19
Philadelphia Chromosome
10/2023 - 10/2010
18
Bronchiolitis Obliterans Syndrome
06/2023 - 06/2003
18
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
08/2022 - 11/2002
13
Neutropenia
04/2023 - 02/2002
11
Febrile Neutropenia
04/2023 - 09/2009
10
Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
12/2023 - 01/2007
9
Disease Progression
12/2023 - 03/2004
9
Fever (Fevers)
04/2023 - 12/2014
8
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
10/2023 - 02/2007
8
Aspergillosis
02/2023 - 06/2004
8
Residual Neoplasm
11/2022 - 11/2006
7
Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2023 - 03/2004
7
Mycoses (Diseases, Fungus)
08/2023 - 01/2008
6
Body Weight (Weight, Body)
10/2023 - 11/2008
6
Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria)
09/2023 - 11/2016
5
Cytomegalovirus Infections (Inclusion Disease)
12/2023 - 05/2007
5
Pathologic Complete Response
10/2023 - 11/2019
5
Sepsis (Septicemia)
04/2023 - 06/2005
4
Lymphoproliferative Disorders (Lymphoproliferative Disorder)
02/2024 - 01/2019
4
COVID-19
04/2023 - 12/2020
4
Infertility (Sterility)
09/2022 - 03/2015
4
Hemolysis
04/2022 - 07/2002
4
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
09/2020 - 01/2017
4
Primary Myelofibrosis (Myelosclerosis)
01/2020 - 01/2019
3
Interstitial Lung Diseases (Interstitial Lung Disease)
04/2023 - 01/2022
3
Acute Promyelocytic Leukemia
12/2022 - 01/2017
3
Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
02/2021 - 04/2014
3
Thrombocytopenia (Thrombopenia)
02/2021 - 09/2010
3
Measles
01/2021 - 07/2013
3
Invasive Fungal Infections
10/2020 - 07/2007
Drug/Important Bio-Agent (IBA)
18
Cyclophosphamide (Cytoxan)
FDA Link
Generic
10/2023 - 08/2008
15
Cyclosporine (Ciclosporin)
FDA Link
Generic
01/2023 - 11/2002
14
Antilymphocyte Serum (Anti-Thymocyte Globulin)
IBA
02/2024 - 04/2002
12
Antigens
IBA
01/2019 - 08/2005
11
fludarabine
IBA
01/2022 - 06/2005
10
Methotrexate (Mexate)
FDA Link
Generic
10/2023 - 11/2006
10
Busulfan (Busulfex)
FDA Link
01/2023 - 04/2002
10
Cytarabine (Cytosar-U)
FDA Link
Generic
08/2022 - 03/2014
9
Tyrosine Kinase Inhibitors
IBA
08/2022 - 09/2015
8
Dexamethasone (Maxidex)
FDA Link
Generic
11/2022 - 04/2014
8
Imatinib Mesylate (Gleevec)
FDA Link
01/2022 - 04/2007
8
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
09/2020 - 02/2002
8
HLA-A Antigens (HLA-A)
IBA
01/2020 - 03/2012
7
thymoglobulin
FDA Link
06/2023 - 06/2010
6
Melphalan (Alkeran)
FDA Link
Generic
01/2021 - 06/2005
5
Dasatinib (BMS 354825)
FDA Link
01/2024 - 10/2010
5
Calcineurin Inhibitors
IBA
10/2023 - 01/2020
5
Etoposide (VP 16)
FDA Link
Generic
12/2022 - 08/2008
5
HLA Antigens (Human Leukocyte Antigens)
IBA
12/2022 - 03/2008
5
Steroids
IBA
05/2022 - 03/2002
5
Immunoglobulin G (IgG)
IBA
02/2021 - 07/2013
5
Alemtuzumab (Campath)
FDA Link
01/2021 - 11/2006
5
Rituximab (Mabthera)
FDA Link
09/2020 - 02/2007
5
Interleukin-2 Receptors (IL 2 Receptor)
IBA
09/2019 - 01/2017
5
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2018 - 12/2004
4
letermovir
IBA
12/2023 - 12/2017
4
Biomarkers (Surrogate Marker)
IBA
09/2023 - 01/2017
4
eculizumab
FDA Link
04/2022 - 11/2016
4
nilotinib
FDA Link
01/2022 - 05/2011
4
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
01/2022 - 03/2010
4
DNA (Deoxyribonucleic Acid)
IBA
10/2020 - 01/2003
4
Anti-Bacterial Agents (Antibiotics)
IBA
09/2020 - 02/2008
4
Ganciclovir (Cytovene)
FDA Link
Generic
06/2020 - 02/2002
4
Enzymes
IBA
06/2016 - 06/2004
4
Tacrolimus (Prograf)
FDA Link
Generic
08/2015 - 06/2005
3
Bortezomib (Velcade)
FDA Link
11/2022 - 02/2018
3
Hemoglobins (Hemoglobin)
IBA
04/2022 - 09/2010
3
Prednisolone (Predate)
FDA Link
Generic
01/2022 - 09/2020
3
Proteins (Proteins, Gene)
FDA Link
01/2022 - 03/2010
3
Inosine Triphosphate (ITP)
IBA
02/2021 - 04/2014
3
Antiviral Agents (Antivirals)
IBA
01/2021 - 01/2016
3
Fluoroquinolones
IBA
09/2020 - 06/2017
Therapy/Procedure
126
Hematopoietic Stem Cell Transplantation
05/2024 - 12/2003
71
Cell Transplantation
02/2024 - 08/2003
69
Transplantation
04/2024 - 07/2002
57
Therapeutics
04/2024 - 03/2002
54
Stem Cell Transplantation
05/2024 - 04/2002
38
Drug Therapy (Chemotherapy)
12/2023 - 04/2008
18
Bone Marrow Transplantation (Transplantation, Bone Marrow)
10/2023 - 03/2003
16
Homologous Transplantation
01/2024 - 04/2002
13
Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
10/2023 - 02/2007
9
Induction Chemotherapy
04/2022 - 01/2010
5
Remission Induction
05/2022 - 09/2009
4
Autologous Transplantation
05/2024 - 10/2013
4
Radiotherapy
10/2023 - 06/2008
4
Haploidentical Transplantation
01/2023 - 04/2013
4
Consolidation Chemotherapy
01/2022 - 01/2010
3
Cell- and Tissue-Based Therapy (Cell Therapy)
06/2023 - 10/2008
3
Immunotherapy
06/2020 - 04/2007